Skip to main content
AAO-HNSF 2024 Annual Meeting & OTO EXPO Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Jason G. Newman, MD

Professor
Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, SC
Mount Pleasant, SC, United States

Dr. Jason G. Newman, at the Medical University of South Carolina, received his medical degree from Thomas Jefferson University Medical School in 1997 and completed residencies in Otolaryngology at Manhattan Eye, Ear & Throat Hospital, New York, NY, (1998-1999), New York Presbyterian Hospital of Columbia and Cornell, and Memorial Sloan Kettering Cancer Center (1999-2002). Following residency, Dr. Newman completed his fellowship in Head and Neck Surgery/Oncology and Microvascular Surgery at the University of Pennsylvania Perelman School of Medicine in 2005. After fellowship, Dr. Newman remained on faculty at Penn until 2022. Dr. Newman is now serving as the Wendy and Keith Wellin Endowed Chair in Head and Neck Surgery, and the Chief of the Hollings Cancer Network at the Medical University of South Carolina.

Dr. Newman's areas of expertise include head and neck mucosal and cutaneous cancer surgery, robotic surgery, anterior cranial base surgery and complex thyroid surgery with special interest in minimally invasive approaches. Dr. Newman also is actively involved in research focused on head and neck cancer clinical trials, genetic signatures for head and neck cancer, and survivorship for head and neck cancer patients.

As the Chief of the Hollings Cancer Network, Dr. Newman is helping to realize the vision of a state-wide network to help care for cancer patients in South Carolina. This network intends to give patients access care closer to home when possible, while seamlessly transitioning them to tertiary care facilities when needed. This strategy will help strengthen the delivery of cancer care, improve patient outcomes, create leadership pathways, increase patient volumes, increase access to clinical trials, and minimize variations in the delivery of care.

Presentation(s):

Email Jason